Truist reiterates Medline stock Buy rating after facility visit
Covered in this story
What has happened since
- Medline is up 0.0% since this was published.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
Truist Securities’s $47 target on $MDLN is on the record and being tracked to Nov 2027 (12-month default), scored on the close that day.
Truist Securities’s track record →Call it yourself
No member calls on $MDLN yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Medline →Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.